R. Daniel Mellon - Concepedia

Author

R. Daniel Mellon

Also Known As

Jensen, Karl, R Daniel Mellon, R. D. Mellon, R. DANIEL MELLON, R. Daniel Mellon, R.D. Mellon, R.Daniel Mellon, Richard Daniel Mellon

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Georgetown University Georgetown University Medical Center United States Food and Drug Administration Center for Drug Evaluation and Research NewPath Research

About

R. Daniel Mellon is an author at Georgetown University specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	855
2	Education	2	2	230
3	Health Sciences	1	1	430
4	Public Health	1	1	22
5	Social Sciences	1	1	35

R. Daniel Mellon

Publications

Citations

H-Index

Page 1

	Year	Citations
Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs Donna A. Volpe, Anne‐Marie Tobin, R. Daniel Mellon, Regulatory Toxicology and Pharmacology Opioid EpidemicDrug TargetHealth SciencesMedicineOpioid Drugs	2011	430
Defining Safe Use of Anesthesia in Children Bob A. Rappaport, R. Daniel Mellon, Arthur F. Simone, New England Journal of Medicine Anesthetic AgentsPerioperative MedicineEducationPharmacotherapyAnesthesia	2011	211
Toxicology Evaluation of Drugs Administered via Uncommon Routes: Intranasal, Intraocular, Intrathecal/Intraspinal, and Intra-Articular Armaghan Emami, Jeff Tepper, Brian Short, International Journal of Toxicology Local PharmacologyUncommon RoutesToxicology TestingPharmacotherapyToxicology Evaluation	2017	88
Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity R. Daniel Mellon, Barbara Bayer Brain Research	1998	51
The Effects of Morphine, Nicotine and Epibatidine on Lymphocyte Activity and Hypothalamic-Pituitary-Adrenal Axis Responses R. Daniel Mellon, Barbara Bayer Journal of Pharmacology and Experimental Therapeutics	1999	48
Regulatory effects of deoxycholic acid, a component of the anti-inflammatory traditional Chinese medicine Niuhuang, on human leukocyte response to chemoattractants Xin Chen, R. Daniel Mellon, Lu Yang, Biochemical Pharmacology InflammationAnti-inflammatoryGranulocyteMedicineLipid Peroxidation	2002	37
Compilation of International Regulatory Guidance Documents for Neuropathology Assessment During Nonclinical General Toxicity and Specialized Neurotoxicity Studies Brad Bolon, Alys Bradley, Mark T. Butt, Toxicologic Pathology NeurotoxicologyNeuropathology AssessmentClinical NeurologyNonclinical EfficacyNonclinical General Toxicity	2010	35
Acute Effects of Morphine on Blood Lymphocyte Proliferation and Plasma IL‐6 Levels Richard A. Houghtling, R. Daniel Mellon, Roderick J. Tan, Annals of the New York Academy of Sciences	2000	30
Can We Panelize Seizure? Ruth Roberts, Simon Authier, R. Daniel Mellon, Toxicological Sciences	2020	25
HESI/FDA workshop on immunomodulators and cancer risk assessment: Building blocks for a weight-of-evidence approach Hervé Lebrec, Frank R. Brennan, Helen G. Haggerty, Regulatory Toxicology and Pharmacology Building BlocksImmunologyProfound ImmunosuppressionPathologyImmunoediting	2015	22

Page 1